Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONSTANT: Lot-to-lot consistency of Sci-B-Vac in adults
2017-001820-22Phase 3Completed
- Sponsor
- VBI Vaccines Inc.
- Start
- Nov 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Hepatitis B vaccine in hepatitis B (HBV) (4 arms), sponsored by VBI Vaccines Inc. Primary endpoint: Primary immunogenicity endpoint. Started Nov 2017; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2017-001820-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001820-22.